Heim600664 • SHA
add
Harbin Pharmaceutical Group Co., Ltd.
Við síðustu lokun
3,73 ¥
Dagbil
3,65 ¥ - 3,78 ¥
Árabil
2,41 ¥ - 4,26 ¥
Markaðsvirði
9,29 ma. CNY
Meðalmagn
48,78 m.
V/H-hlutf.
15,63
A/V-hlutfall
-
Aðalkauphöll
SHA
Viðskiptafréttir
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (CNY) | sep. 2024info | Breyting á/á |
|---|---|---|
Tekjur | 4,11 ma. | 8,54% |
Rekstrarkostnaður | 833,10 m. | 0,85% |
Nettótekjur | 164,90 m. | 52,98% |
Hagnaðarhlutfall | 4,01 | 41,20% |
Hagnaður á hvern hlut | — | — |
EBITDA | 318,87 m. | 26,26% |
Virkt skatthlutfall | 23,46% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (CNY) | sep. 2024info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 3,13 ma. | 13,03% |
Heildareignir | 14,27 ma. | 2,51% |
Heildarskuldir | 8,32 ma. | -3,45% |
Eigið fé alls | 5,95 ma. | — |
Útistandandi hlutabréf | 2,52 ma. | — |
Eiginfjárgengi | 1,80 | — |
Arðsemi eigna | 4,51% | — |
Ávöxtun eigin fjár | 8,25% | — |
Peningaflæði
Breyting á handbæru fé
| (CNY) | sep. 2024info | Breyting á/á |
|---|---|---|
Nettótekjur | 164,90 m. | 52,98% |
Handbært fé frá rekstri | 105,03 m. | -61,67% |
Reiðufé frá fjárfestingum | -35,33 m. | 74,29% |
Reiðufé frá fjármögnun | -173,45 m. | -5.358,43% |
Breyting á handbæru fé | -104,01 m. | -174,49% |
Frjálst peningaflæði | -77,99 m. | 22,01% |
Um
Harbin Pharmaceutical Group Co., Ltd. is a Chinese partially state-owned company engaged in the research & development, manufacture, and sale of pharmaceutical products. HPGC medication offerings include traditional Chinese medicine and biopharmaceuticals; its main offerings include antibiotics, including amoxicillin and penicillin, and dietary supplements, including zinc gluconate and calcium gluconate.
The company owns both Renmintongtai, a drugstore chain and medical wholesaler for the domestic market, and GNC, a U.S.-based international retailer of supplements and wellness products. Wikipedia
Stofnsett
1988
Vefsvæði
Starfsfólk
9.853
